The Ministry of Health has awarded the contract to build the IT system for the National Bowel Screening Programme (NBSP) to Deloitte, leveraging Salesforce technology.
The consultancy giant has been working with the Ministry over the past few months on planning and designing the solution, under the banner of the National Screening Solution (NSS).
Specifically, the technology is based around the Salesforce suite of solutions in conjunction with Deloitte’s Health Connect accelerator.
The NSS will provide the technology to run the NBSP as district health boards (DHBs) progressively join and start bowel screening.
Seven of the country’s 20 DHBs are now offering free bowel screening to eligible 60 to 74 year olds with the rest expected to join the national programme by the end of 2021.
According to Deborah Woodley - deputy director-general of Population Health and Prevention - the partnership with Deloitte has already delivered the blueprint for the design, with the department now moving to the build phase.
“This is an important IT system that will enable the nationwide roll-out of bowel screening,” Woodley said. “It will manage the participant’s progress through the screening process by ensuring the secure and effective flow of relevant information between the parties involved.”
Woodley said the current interim IT solution, that was initially designed to support the bowel screening pilot in Waitemata DHB, is unable to be expanded to support the national population of eligible screening participants.
The NSS will initially run alongside the interim IT solution, currently being used by the DHBs already participating in the programme, before ultimately replacing it.
Woodley said the new platform will initially support the NBSP but has the capability to support other screening programmes in future, subject to separate approval and funding decisions.
“The Ministry views the NSS as a long-term strategic asset which it hopes overtime will support multiple screening programmes,” Woodley added.
New Zealand has one of the highest rates of bowel cancer in the developed world.
“Our team is very excited to be making a real impact on the health and well-being of New Zealanders,” added Thorsten Engel, partner at Deloitte in New Zealand.
“The NSS platform will provide the fundamental capabilities necessary to reach our population where it matters the most and supports the nationwide roll-out of a screening programme that will save lives.”